logo-loader
viewPan African Resources plc

Pan African Resources guides to improved full year earnings

Headline earnings per share was guided to rise 15%-25% to between 1.14 cents and 1.24 cents

Pan African Resources plc - earnings guided higher

Pan African Resources plc (LON:PAF) said full year earnings per share from its continuing operations are likely to have grown 124%-134%, boosted by the reversal of an impairment charge. 

In a trading statement on Wednesday afternoon, South Africa-based gold miner said total EPS are likely to come in for the 12 months to 30 June at between 1.63 US cents and 2.32 US cents. This compares with a loss per share a year ago of 6.79 cents.

Guidance for EPS from continuing operations was given as 1.93 cents to 2.02 cents, versus 0.86 cents a year earlier. 

Total EPS benefited from the reversal of an impairment charge of US$17.9mln which was recognised following commencement of development at Evander Mines’ 8 Shaft Pillar Project, otherwise 'headline' EPS was guided to rise 15%-25% to between 1.14 cents and 1.24 cents.

The group’s presentation currency changed for its financial results changed to US dollars from pounds sterling. Last year total EPS was 5.15p and from continuing operations 0.63p.

‘Headline’ EPS from continuing operations are likely to fall 23%-13% as the weighted average number of shares in issue increased by 6.6%, the South African rand weakened against the dollar and the average gold price dipped slightly over the year.

The rand was down 10.4% against the dollar, from ZAR14.19 to ZAR12.85, while the average gold price received was down 2.7% to US$1,266 per oz.

Pan African reported in July that gold output rose by 7.5% to 172,442 ounces, or 54% when considered in terms of continuing operations, having stopped high-cost underground mining at Evander Mines, while successfully commissioning the Elikhulu tailings retreatment plant and achieving a significant increase in production at Barberton Mines.

Quick facts: Pan African Resources plc

Price: 10.55 GBX

AIM:PAF
Market: AIM
Market Cap: £203.44 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Pan African Resources plc named herein, including the promotion by the Company of Pan African Resources plc in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Investor Update: Faron Pharma encouraged by Clevegen efficacy and tolerability

Top stories from the Proactive Investors UK newsroom. Faron Pharmaceuticals (LON:FARN) has reported increased immune cell activity in its ongoing phase I/II trial of solid tumour cancer treatment Clevegen. All nine patients treated also tolerated high dose levels. South African gold...

on 12/7/19

2 min read